RxDoctor Payments Data

Sophie Toya

Pulmonary Disease · Saginaw, MINPI 1225367147

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,000 of the $2,396 with a category attached, or 83.5%. Cardinal Health 110 LLC accounts for 83.5% of it on its own, with 10 other manufacturers making up the rest.

$2,396in general payments, 2019–2025

Across 29 payments — averaging $82.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cardinal Health 110 LLC$2K
  • Sunovion Pharmaceuticals Inc.$105
  • Boehringer Ingelheim$89
  • GSK$86
  • Sanofi$24
  • BD$21
  • plus $72 from 5 others
$233,323in research payments, 2019–2025

Across 17 payments — averaging $13,725 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$126K
  • Astrazeneca UK Limited$35K
  • Sanofi US Services Inc.$33K
  • CSL Behring$22K
  • Chiesi USA, Inc.$18K

What the payments were for

  • Consulting fees$2,00083%
  • Food & beverage$37516%
  • Education$211%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,396 in reported general payments places this provider in the 55th percentile of 463 pulmonary disease providers in Michigan.

See all pulmonary disease providers in Michigan

Other pulmonary disease in Saginaw

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →